DWP
FOLD

Destiny Wealth Partners’s Amicus Therapeutics FOLD Stock Holding History

Destiny Wealth Partners’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,380
Closed -$34.4K – 490
2026
Q1 		$34.4K Buy
+2,380
New +$34.1K ﹤0.01% 505

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Destiny Wealth Partners's FOLD Position: Q2 2026 in Review

Destiny Wealth Partners sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 2,380 shares — an estimated $34.4K sold.

Destiny Wealth Partners first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $34.4K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Destiny Wealth Partners reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Destiny Wealth Partners sold 2,380 Amicus Therapeutics shares in Q2 2026, an estimated $34.4K.
  • Destiny Wealth Partners first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
  • Destiny Wealth Partners's Amicus Therapeutics position peaked at $34.4K in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Destiny Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.